Physician profile
James E Honet
NPI 1093794224
$9,718.08
in general payments reported to CMS, 2019-2025
49 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what 75% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,477 · 2020: $850 · 2021: $1,122 · 2022: $891 · 2023: $2,249 · 2024: $1,495 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,373 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,372.74 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,997.22 | 2019-2024 | Senza |
| Medtronic, INC. | $958.16 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Globus Medical, INC. | $756.55 | 2025 | Senza, Vyrsa V1, Senza |
| Collegium Pharmaceutical, INC. | $750.29 | 2019-2025 | Xtampza, Belbuca |
| Boston Scientific Corporation | $677.38 | 2019-2025 | Intracept |
| Medtronic USA, INC. | $609.66 | 2019-2020 | |
| Abbvie INC. | $463.17 | 2022-2025 | |
| Nalu Medical, INC. | $331.78 | 2021-2025 | Nalu Neurostimulation System |
| Allergan, INC. | $301.19 | 2019-2022 | |
| Relievant Medsystems, INC. | $271.88 | 2020-2022 | |
| Amgen INC. | $229.20 | 2019-2022 | |
| Saluda Medical Americas, INC. | $228.17 | 2023-2025 | Evoke Scs, Evoke |
| Abbott Laboratories | $220.99 | 2020-2025 | Proclaim, Eterna |
| Curonix LLC | $174.03 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Tersera Therapeutics LLC | $144.83 | 2019 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Honet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.